|
|
- 2018
Drospirenone-containing oral contraceptives and venous thromboembolism: an analysis of the FAERS databaseDOI: 10.2147/OAJC.S161737 Keywords: drug safety, Yaz, venous thrombotic events, FDA adverse event reporting system, disproportionality Abstract: Substantial evidence suggests that drospirenone-containing oral contraceptives may cause a higher risk of venous thrombotic events than earlier-generation oral contraceptives
|
